{
  "id": "583018be429c8c15",
  "title": "T - MAXIMUM Pharmaceutical Allogeneic CAR - T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma",
  "description": "20251221T183000Z",
  "content": "",
  "source": "thailand-business-news.com",
  "source_url": "https://www.thailand-business-news.com/pr-news/t-maximum-pharmaceuticals-allogeneic-car-t-therapy-mt027-receives-fda-ind-clearance-to-proceed-to-phase-ii-clinical-trial-for-recurrent-glioblastoma",
  "published_at": "20251221T183000Z",
  "fetched_at": "2025-12-22T00:24:16.044990+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Thailand",
  "raw_data": {
    "url": "https://www.thailand-business-news.com/pr-news/t-maximum-pharmaceuticals-allogeneic-car-t-therapy-mt027-receives-fda-ind-clearance-to-proceed-to-phase-ii-clinical-trial-for-recurrent-glioblastoma",
    "url_mobile": "",
    "title": "T - MAXIMUM Pharmaceutical Allogeneic CAR - T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma",
    "seendate": "20251221T183000Z",
    "socialimage": "https://www.thailand-business-news.com/wp-content/uploads/2024/06/bangkok-river-skyline-sunset.avif",
    "domain": "thailand-business-news.com",
    "language": "English",
    "sourcecountry": "Thailand"
  }
}